ÂÜÀòÂÒÂ×

Greg Zante is the current Chief Financial Officer at Viking Therapeutics, Inc. Greg has held various finance and administration positions in companies such as Dance Biopharm, Sangamo Therapeutics, Calyx Therapeutics, and Matrix Pharmaceuticals. With a BA in Business-Economics from UCLA, Greg has a strong background in finance and has steadily advanced their career in the field.